NanoplasmidTM Whitepaper:
Eliminating antibiotic resistance gene transfer risks in cell & gene therapies

Download Now

NanoplasmidTM
Apply for the Nanoplasmid AAV Construct Giveaway

Learn More

CRISPR RNP-Based Genome Editing with cGMP Capacity

Learn More

NanoplasmidTM
A next-generation, small cloning backbone with a patented antibiotic-free selection system.

Learn More

For More Product Information >

Aldevron Breakthrough Blog

Read the Latest

pALD-CV77-Luciferase
In Stock, Royalty-Free, Reporter Plasmid

Learn More

Work at Aldevron

Learn More

Platforms

ald-HomepageIcons-plasmid-2019-01

Plasmid DNA Production

High-quality plasmid DNA production for a wide range of research, preclinical, clinical, and diagnostic applications.

Learn more

ald-HomepageIcons-mrna-2019-04

mRNA Production

High-quality, scalable mRNA production meeting a wide range of requirements.

Learn more

ald-HomepageIcons-protein-2019-02

Protein Production

Gene-to-protein services, including custom enzyme production, recombinant antibodies and proteins.

Learn more

Services

research-grade-icon

Research Grade

Our research-grade production facilities provide the flexibility needed to offer competitive pricing and rapid turnaround times while still maintaining the quality our clients expect.

Learn more

gmp-source-icon

GMP-Source®

A faster, cost-effective alternative to cGMP production, GMP-Source® (GMP-S) can be manufactured to standard or customizable specifications.

Learn more

cGMP-Service-Icon

cGMP

Driven by a comprehensive quality assurance process, we produce cGMP plasmid DNA in segregated ISO-classified manufacturing suites ensuring the highest quality products with each and every order.

Learn more

Recent News

Aldevron Launches Eureca-V™ MAD7®, a Type-V CRISPR Nuclease

Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, launches Eureca-V™...

Webinar: How a Sponsored CMC Platform Accelerates mRNA Projects to the Clinic

On the pathway to GMP manufacturing in support of clinical trials, multiple technology transfers may correlate to an increase in complexity and risk...

Aldevron co-founder named to board of MIT's Whitehead Institute

Michael Chambers, the founding CEO of Aldevron, has been elected to the board of directors for the Whitehead Institute at the Massachusetts Institute...

Recent Blog Posts

Innate Immunity and Cell Death

The bane of non-viral cell and gene therapy In my previous discussions on the benefits of NanoplasmidTM vectors, I touched on eliminating protein and...

Apply for the Nanoplasmidᵀᴹ AAV Construct Giveaway

Overcoming challenges, increasing yields In efforts to bring the next-generation of plasmid technology to the cell and gene therapy space, Aldevron...

Webinar: How a Sponsored CMC Platform Accelerates mRNA Projects into the Clinic

Streamlining development, ensuring quality and safety When discussing mRNA development, the complexity across a variety of modalities can give pause...

About Aldevron

We provide high-quality plasmid DNA, proteins, enzymes, and other biologicals to help our partners achieve ground-breaking science throughout a variety of life science applications. From contract services to comprehensive solutions, we supply what you need, when you need it, with expert support at every stage of development and production.

Learn More

Innovative Science. Consistent Biologics. Experienced Partner.

Contact us about our comprehensive development and manufacturing services and how we can help you navigate the entire pharmaceutical development cycle.

 

contact us